None
Quote | PRA Health Sciences Inc. (NASDAQ:PRAH)
Last: | $165.21 |
---|---|
Change Percent: | -1.67% |
Open: | $167.73 |
Close: | $165.21 |
High: | $168.76 |
Low: | $164.28 |
Volume: | 13,408,593 |
Last Trade Date Time: | 06/30/2021 04:42:56 am |
News | PRA Health Sciences Inc. (NASDAQ:PRAH)
Over 70 multi-billion dollar deals announced in the first half of the year. SPAC IPOs pick up pace and Chamath Palihapitiya files four new biotech focused SPACs. Icon completes the acquisition of PRA Health Sciences. For further details see: Merger Arbitrage Mondays - MK...
Zhanna Hapanovich/iStock via Getty Images EQT AB and Goldman Sachs Inc.'s (GS) investment arm are reportedly in advanced discussions to buy contract-research organization Parexel for close to $9B including debt. A sale to EQT and Goldman may be announced this week, according a WSJ report, whi...
Message Board Posts | PRA Health Sciences Inc. (NASDAQ:PRAH)
Subject | By | Source | When |
---|---|---|---|
PRAH bullish 57.20 | stocktrademan | investorshub | 10/08/2016 5:06:58 PM |
News, Short Squeeze, Breakout and More Instantly...
PRA Health Sciences Inc. Company Name:
PRAH Stock Symbol:
NASDAQ Market:
PRA Health Sciences Inc. Website:
DT Midstream Set to Join S&P MidCap 400 DT Midstream Set to Join S&P MidCap 400 PR Newswire NEW YORK , June 28, 2021 /PRNewswire/ -- DT Midstream Inc. (NYSE: DTM) will replace PRA Health Sciences Inc. (NASD: PRAH) in the S&P MidCap 400 effective p...
Through this strategic partnership, the network aims to reach more than 25,000 physicians and 40 million patients, accelerating trial recruitment and enrollment efforts and expanding patients’ access to clinical research Veradigm®, a leading provider of healthcar...
Strengthening Board of Directors with Expertise in Innovative Product Launches NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiat...